BNP PARIBAS FINANCIAL MARKETS - IDERA PHARMACEUTICALS INC ownership

IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 45 filers reported holding IDERA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of IDERA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$22,000
+69.2%
60.0%0.00%
Q3 2020$13,000
-93.3%
6
-94.5%
0.00%
Q2 2020$195,000
+35.4%
1090.0%0.00%
Q1 2020$144,000
-27.3%
1090.0%0.00%
Q4 2019$198,000
-97.2%
109
-95.5%
0.00%
Q3 2019$6,982,000
+8.2%
2,4160.0%0.00%
Q2 2019$6,451,000
-40.5%
2,416
-43.2%
0.00%
Q1 2019$10,850,000
+1729.7%
4,255
+1888.3%
0.00%
Q4 2018$593,000
-86.7%
214
-57.2%
0.00%
Q3 2018$4,455,0005000.00%
Other shareholders
IDERA PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
ABG Innovation Capital Partners III GP Ltd 56,250$68,0000.23%
Virtu Financial LLC 325,330$390,0000.04%
HOLLENCREST CAPITAL MANAGEMENT 141,000$169,0000.02%
Clear Creek Financial Management, LLC 49,696$60,0000.01%
Palo Alto Investors LP 77,044$92,0000.01%
ACADIAN ASSET MANAGEMENT LLC 738,620$886,0000.00%
MARSHALL WACE, LLP 477,449$573,0000.00%
WADE G W & INC 35,000$42,0000.00%
TWO SIGMA ADVISERS, LP 599,471$719,0000.00%
BRYN MAWR TRUST Co 33,892$41,0000.00%
View complete list of IDERA PHARMACEUTICALS INC shareholders